Загрузка...
Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension
Hypertension is particularly prevalent in patients aged ⩾65 years, those with a body mass index ⩾30 kg m(−2), Blacks and those with type II diabetes. Here we report a prespecified secondary analysis of the efficacy of amlodipine (10 mg day(−1)), olmesartan medoxomil (40 mg day(−1)), a combination of...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Publishing Group
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2963900/ https://ncbi.nlm.nih.gov/pubmed/20164847 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jhh.2010.5 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|